Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

ABSORB II Acute gain for BVS vs. DES: 1.15
ABSORB II Acute gain for BVS vs. DES: 1.15
by anderson
vs. 1.46 mm, . p < 0.0001; . IVUS showed lower ...
The PROSPECT ABSORB Trial:
The PROSPECT ABSORB Trial:
by lucy
Randomized Evaluation of Vulnerable Plaque Treatme...
ABSORB China : Two-Year Clinical
ABSORB China : Two-Year Clinical
by bitechmu
Results in Patients with Coronary Artery Disease R...
ABSORB China
ABSORB China
by mitsue-stanley
: . Two-Year Clinical . Results in Patients with ...
The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb
The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb
by briana-ranney
Everolimus. Eluting . Bioresorbable. Vascular S...
The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb
The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb
by conchita-marotz
Everolimus. Eluting . Bioresorbable. Vascular S...
A Randomized
A Randomized
by tatyana-admore
Comparison of . Everolimus-­. Eluting . Absorb B...
A Randomized Comparison of
A Randomized Comparison of
by melanie
Everolimus-­. Eluting . Absorb Bioresorbable Vasc...
Outcomes of 10.312 Patients Treated with
Outcomes of 10.312 Patients Treated with
by lindy-dunigan
Everolimus. -eluting . Bioresorbable. Scaffolds ...
Outcomes of 10.312 Patients Treated with
Outcomes of 10.312 Patients Treated with
by sherrill-nordquist
Everolimus. -eluting . Bioresorbable. Scaffolds ...
Everolimus-eluting Bioresorbable Vascular Scaffolds in Pati
Everolimus-eluting Bioresorbable Vascular Scaffolds in Pati
by debby-jeon
The ABSORB III trial. Dean J. Kereiakes, MD, . St...
Un update
Un update
by giovanna-bartolotta
clinico. in . tema. di BVS. Bernardo Cortese. I...